BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26323466)

  • 1. Large multinodular goiter--outpatient radioiodine treatment.
    Kaniuka-Jakubowska S; Lewczuk A; Mizan-Gross K; Piskunowicz M; Zapaśnik A; Lass P; Sworczak K
    Endokrynol Pol; 2015; 66(4):301-7. PubMed ID: 26323466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
    Munigoti S; Samat A; Keston Jones M
    Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082
    [No Abstract]   [Full Text] [Related]  

  • 7. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
    Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Roque C; Vasconcelos CA
    J Endocrinol Invest; 2018 Sep; 41(9):1019-1028. PubMed ID: 29353393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' disease induced by Na(131)I therapy for toxic multinodular goitre.
    van Leussen JJ; Edelbroek MA; Talsma MA; de Heide LJ
    Neth J Med; 2000 Nov; 57(5):194-7. PubMed ID: 11185482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine treatment of multinodular non-toxic goitre.
    Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
    BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
    Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre.
    Danaci M; Feek CM; Notghi A; Merrick MV; Padfield PL; Edwards CR
    N Z Med J; 1988 Nov; 101(858):784-6. PubMed ID: 3194075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium.
    Vannucchi G; Chiti A; Mannavola D; Dazzi D; Rodari M; Tadayyon S; Beck-Peccoz P; Fugazzola L
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1081-8. PubMed ID: 15871016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic results of radioiodine therapy of hyperthyroid thyroid gland diseases].
    Debrand-Passard A; Barzen G; Richter W; Wenzel KW; Felix R
    Med Klin (Munich); 1994 Jun; 89(6):319-23. PubMed ID: 8072455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.